Altimmune, Inc. Common Stock
€2.518
EUR
Last updated on --.
24h volume2.15M
24h highest2.5788 EUR
24h lowest2.4877 EUR
24h Price movement+1.03%
ALT recent prices
24 Hours
+1.03%+€0.025788
30 days
+3.93%+€0.094556
60 days
-3.64%-€0.094556
90 days
-36.18%-€1.419
Key data
Previous close2.4928 EUR
Market cap471.42M EUR
Volume2.15M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.40401 EUR
Net income (FY)-78.29M EUR
Revenue (FY)30.95K EUR
Last report date13 May 2026
About Altimmune, Inc. Common Stock
HeadquartersGAITHERSBURG
Employees (FY)57.00
Revenue per employee (FY)542.91 EUR
Net income per employee (FY)-1.37M EUR
Listed onNasdaq
ALT conversion tables
 |  |
|---|---|
| 0.5 ALT | 1.259 EUR |
| 1 ALT | 2.518 EUR |
| 5 ALT | 12.59 EUR |
| 10 ALT | 25.18 EUR |
| |
|---|---|
| 0.5 EUR | 0.19852 ALT |
| 1 EUR | 0.39704 ALT |
| 5 EUR | 1.985 ALT |
| 10 EUR | 3.970 ALT |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ALT is trading at €2.518, +1.03% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ALT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ALT is currently trading at €2.518, +1.03% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ALT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ALT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ALT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ALT's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Altimmune, Inc. Common Stock's market cap is currently 471.42M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.15M
24h highest2.5788 EUR
24h lowest2.4877 EUR
24h Price movement+1.03%
Start trade with ALT Perpetual
Sign up to trade